Multiple system atrophy is a rare brain disorder that gets worse over time and affects movement, balance, and automatic body functions like blood pressure and bladder control. Early symptoms of multiple system atrophy can include dizziness when standing, stiffness, slowness, shaking, trouble walking, constipation, and problems with urination. It most often starts in adulthood, usually in the 50s or 60s, and multiple system atrophy is lifelong. Not everyone will have the same experience. Treatment does not cure multiple system atrophy, but medicines, physical therapy, speech therapy, and support for blood pressure, breathing, sleep, and bladder symptoms can help, and the condition can shorten life in many people.
How many people live with Multiple system atrophy?
Worldwide, multiple system atrophy is estimated to affect roughly 150,000 to 390,000 people, based on reports suggesting about 1.9 to 4.9 people out of every 100,000 have the condition; this is an estimate rather than a direct count, and the range varies because studies use different ways of diagnosing it (Orphanet, 2023). In the United States, about 15,000 to 50,000 people are thought to be living with multiple system atrophy (National Institute of Neurological Disorders and Stroke, 2023).
Overview
Multiple system atrophySymptoms
Multiple system atrophy often causes dizziness on standing, balance problems, slurred speech, and stiffness or slow movement. Many also have bladder, bowel, or sexual problems. Early symptoms of multiple system atrophy can look like Parkinson's disease.
Outlook and prognosis
Multiple system atrophy usually worsens over time and affects movement, balance, blood pressure, and everyday independence. Many living with multiple system atrophy need more support as symptoms progress. Care can ease symptoms and help with comfort, safety, and planning.
Causes and risk factors
The cause of Multiple system atrophy is unknown and usually is not inherited. Risk appears to rise with age, and some studies suggest a slightly higher risk in men, but no clear lifestyle or environmental cause has been proven.
Genetic influences
Genetics do not seem to be a major cause of Multiple system atrophy. Most cases are not inherited, although certain genetic variations may slightly affect risk, and research is ongoing to better understand this link.
Diagnosis
Multiple system atrophy is diagnosed from a neurologic exam, symptom history, and how symptoms change over time. Brain imaging and tests of blood pressure, bladder, sleep, or movement can support the diagnosis. There is no single definitive test.
Treatment and drugs
Treatment for multiple system atrophy focuses on easing symptoms and protecting day-to-day function. Medicines may help dizziness on standing, stiffness, bladder problems, sleep changes, and constipation. Many living with multiple system atrophy also benefit from physical, speech, and swallowing therapy.
Symptoms
Multiple system atrophy often begins with a mix of changes that may not seem connected at first, such as dizziness on standing, bladder trouble, or new problems with balance. Early on, this might look like getting lightheaded after a shower, rushing to the bathroom more often, or feeling less steady when turning around. Some of the early symptoms of multiple system atrophy can be mistaken for dehydration, aging, Parkinson-like illness, or a sleep problem. As the condition progresses, movement, blood pressure control, sleep, speech, and swallowing can all be affected.
Blood pressure can drop suddenly when standing, causing lightheadedness, blurry vision, weakness, or fainting. For many people with multiple system atrophy, this can make showers, meals, or getting out of bed feel unexpectedly hard.
Needing to urinate often, feeling sudden urgency, leaking urine, or having trouble fully emptying the bladder are common. This can mean planning outings around bathroom access or waking several times at night.
Constipation is common, and many people also notice sexual problems such as erection difficulties or reduced arousal. These can be early signs that the nerves controlling automatic body functions are being affected.
Movements may become slow and stiff, and the body can feel heavy or less fluid. In multiple system atrophy, this often affects walking, getting dressed, turning in bed, or using buttons and utensils.
How people usually first notice Multiple system atrophy?
Many people with multiple system atrophy first notice something that feels slightly off rather than dramatic: dizziness or faintness when standing up, new problems with balance, or a body that seems to move more slowly and stiffly than before. For others, how multiple system atrophy is first noticed is through early bladder problems, constipation, erectile dysfunction, softer speech, or sleep changes such as acting out dreams, often before the full pattern becomes clear. These first warning signs can overlap with Parkinson disease or other conditions, so noticing a cluster of symptoms over time is often what leads to a medical evaluation.
Types of Multiple system atrophy
Multiple system atrophy can affect movement and automatic body functions in different ways, so the day-to-day picture is not always the same. Doctors mainly describe two types of Multiple system atrophy based on which problems stand out first or most strongly. The balance of symptoms can shift over time, and many living with Multiple system atrophy eventually have features of both patterns.
MSA-P
This type is mainly marked by Parkinson-like movement problems such as slowness, stiffness, and trouble starting to move. A person may notice a shuffling walk, softer speech, or increasing difficulty with buttons, turning in bed, or getting up from a chair. Problems with blood pressure, bladder control, or sexual function are also common.
MSA-C
This type is mainly marked by cerebellar problems, which affect balance and coordination. Some may find they walk unsteadily, reach past objects, or develop slurred speech, especially when symptoms first begin. Autonomic symptoms such as dizziness on standing, constipation, or bladder problems can happen here too.
Can I slow down the onset of symptoms?
Right now, there is no proven way to meaningfully delay the start of symptoms in multiple system atrophy, and no lifestyle change or medicine has been shown to prevent it. Healthy habits like staying active, sleeping well, not smoking, and managing blood pressure and other heart-health problems are good for overall health, but research has not clearly shown that they push back when this condition begins; this is still an active area of research. While that can feel discouraging, keeping up with general health and getting new symptoms checked early may still help you feel more prepared and supported.
What genetics can tell you about symptoms
Genetics can tell us a little about symptoms in multiple system atrophy, but not enough yet to reliably predict exactly which symptoms someone will have, how severe they will be, or when they will start. Researchers have found that inherited differences in some genes may slightly affect risk and may help explain why some people mainly have movement problems while others have more trouble with blood pressure, bladder control, or balance, but these links are not strong enough for routine symptom forecasting. For most people living with multiple system atrophy, symptoms are shaped by a mix of biology that is still not fully understood, rather than by a single gene test result.
Causes and risk factors
Doctors do not know the exact cause of multiple system atrophy, but it involves an abnormal buildup of a protein called alpha-synuclein in parts of the brain. Multiple system atrophy is usually not inherited, though some gene changes may slightly affect risk and family history is uncommon. Age is the clearest biological risk factor, and symptoms most often begin after age 50. Researchers are still learning how these pieces fit together. Possible environmental triggers and other lifestyle risk factors for multiple system atrophy have been studied, but no clear cause has been proven and there is no known way to prevent it.
What are the most common causes or risk factors?
The exact cause of multiple system atrophy is still unknown, but it is linked to a harmful buildup of an abnormal protein in the brain that damages areas controlling movement, blood pressure, breathing, and bladder function. The clearest risk factor is age, since it usually begins in later adulthood, most often in the 50s or 60s, and it may be slightly more common in men. Unlike some brain conditions, it usually does not run in families, so strong inherited risk has not been shown, and no clear lifestyle or environmental cause has been proven.
Environmental and biological risk factors
The exact cause of multiple system atrophy is still not clear, and the list of confirmed risk factors is short. Most cases of multiple system atrophy begin in later adulthood rather than early life, and the condition appears to be a little more common in people assigned male at birth. Researchers are still exploring how outside influences interact with our inner biology. If you are looking for known risk factors for multiple system atrophy, age is the main established one, while most environmental links remain uncertain.
Multiple system atrophy usually starts in adulthood, most often after age 50. Increasing age is the clearest known biological risk factor, while the condition is rare in younger adults.
Multiple system atrophy is reported somewhat more often in people assigned male at birth than in people assigned female at birth. This difference is modest, so sex alone is not a strong predictor of who will develop it.
Researchers have looked at long-term exposure to pesticides, solvents, metals, and similar chemicals as possible environmental risks for multiple system atrophy. So far, the findings have been mixed, which means no specific exposure is currently accepted as a proven cause.
Genetic risk factors
For most people living with Multiple system atrophy, there is no clear inherited cause, and the condition usually appears without a strong family pattern. Some risk factors are inherited through our genes. Researchers are still sorting out the genetic risk factors for multiple system atrophy, and so far only a few uncommon gene links have been found.
Family history: Multiple system atrophy rarely runs in families, so most people with MSA do not have a parent or sibling with the same condition. When it does seem to cluster in a family, doctors may consider an inherited genetic factor, but this is uncommon.
Inheritance pattern: Multiple system atrophy does not usually follow a clear inheritance pattern passed from one generation to the next. For many families, this means relatives are not thought to face a high risk from one single known gene.
SNCA changes: Rare changes in or near the SNCA gene have been linked with a higher chance of Multiple system atrophy. This gene affects α-synuclein, a protein that builds up abnormally in MSA, but these genetic changes explain only a small number of cases.
COQ2 changes: Changes in the COQ2 gene have been linked to Multiple system atrophy in some studies, especially in a small number of families and in some East Asian groups. Other studies have found mixed results, so COQ2 is considered a possible risk factor rather than a common cause.
Other genes: Researchers have studied several other genes, including some linked to Parkinson's disease and related brain conditions, but none are confirmed causes for most people with Multiple system atrophy. This is one reason genetic testing often does not give a clear answer.
Lifestyle risk factors
Multiple system atrophy is not known to be caused by lifestyle in the same way as many common chronic diseases. Still, when people ask about lifestyle risk factors for multiple system atrophy, the most useful focus is on habits that can worsen blood pressure instability, movement problems, sleep issues, swallowing difficulty, and overall day-to-day function. Lifestyle choices can therefore affect symptom burden, safety, and the pace at which complications appear.
Too little movement can speed up deconditioning, muscle weakness, stiffness, and loss of balance in multiple system atrophy. Regular, supervised activity may help preserve mobility, reduce falls, and support daily function for longer.
Poor hydration can make orthostatic hypotension worse, causing more dizziness, fainting, and fatigue when standing. Drinking enough fluids, if medically appropriate, can help support blood pressure and reduce symptom flare-ups.
Alcohol can lower blood pressure further and intensify lightheadedness or blackouts in people with multiple system atrophy. It may also worsen balance, sleep quality, and bladder symptoms.
Big meals, especially those rich in rapidly absorbed carbohydrates, can trigger post-meal drops in blood pressure. Smaller, more evenly spaced meals may reduce dizziness and weakness after eating.
Risk prevention
For multiple system atrophy, there is no proven way to prevent the disease itself, because experts do not yet know exactly why it starts. Prevention is mainly about lowering the chance of complications, staying as safe and active as possible, and treating symptoms early. Prevention is about lowering risk, not eliminating it completely.
Many living with multiple system atrophy have blood pressure drops when standing, which can lead to dizziness or fainting. Drinking enough fluids, using compression garments if advised, and standing up slowly may help reduce falls and blackouts.
Balance problems and stiffness can make simple moments, like turning in the kitchen or getting out of bed at night, less steady. Physical therapy, mobility aids, and removing home tripping hazards can lower the risk of injury.
Multiple system atrophy can affect swallowing, raising the risk of choking and chest infections. A speech and swallowing specialist can suggest safer food textures, eating strategies, and when to consider further nutrition support.
Bladder problems can lead to urgency, leakage, trouble emptying, and repeated urinary infections. Early treatment, timed bathroom visits, and checking for retained urine may help prevent complications.
Can you prevent Multiple system atrophy?
No, there is no known way to prevent multiple system atrophy at this time. Its exact cause is still not fully understood, and no lifestyle change, medicine, or screening test has been proven to stop it from starting. Staying generally healthy is still good for overall brain and body health, but it has not been shown to prevent this condition.
Transmission
Multiple system atrophy is not contagious, so it cannot be caught from someone through touching, coughing, kissing, sex, food, or shared spaces. For many living with Multiple system atrophy, a common worry is whether family members are at risk, but this condition is usually not passed directly from parent to child. Researchers are still studying how Multiple system atrophy is inherited, and while genes may play a small part in some people, most cases seem to happen sporadically rather than through a clear family pattern. In short, the genetic transmission of Multiple system atrophy is not understood as a regular inherited disease, and it is not considered infectious.
When to test your genes
For multiple system atrophy, genetic testing is not routinely recommended for early detection because there is no well-established predictive gene test for typical MSA. Testing may be worth discussing if symptoms are unusual, start young, or your family history suggests inherited ataxia or parkinsonism, because results can help rule out look-alike conditions and guide care.
Diagnosis
Multiple system atrophy is usually diagnosed by putting together a pattern of changes over time rather than from one single test. People with Multiple system atrophy may have a mix of movement problems, fainting or dizziness when standing, bladder trouble, and sleep-related symptoms, but these can overlap with Parkinson's disease and other nerve conditions. It’s natural to worry when symptoms don’t have a clear explanation, and how Multiple system atrophy is diagnosed often involves several visits and targeted tests.
Doctors ask about symptoms such as balance problems, stiffness, slowness, speech or swallowing changes, bladder issues, constipation, and drops in blood pressure. The timing and combination of these symptoms can make the diagnosis of Multiple system atrophy more likely.
A neurologist checks walking, coordination, muscle tone, reflexes, eye movements, and speech. This helps show whether both movement control and the automatic body functions are being affected.
Measurements are taken lying down and again after standing to look for a significant blood pressure drop, called orthostatic hypotension. This can help explain dizziness, fainting, or feeling weak after getting out of bed or up from a chair.
MRI scans are often used to look for patterns of shrinkage or signal changes in parts of the brain involved in movement and balance. MRI cannot confirm Multiple system atrophy on its own, but it can support the diagnosis and help rule out stroke, normal pressure hydrocephalus, or other causes.
How is Multiple system atrophy diagnosed?
Multiple system atrophy is usually diagnosed based on a careful review of symptoms and a neurologic exam, especially when someone has a mix of movement problems, balance trouble, and body control problems such as dizziness from a drop in blood pressure when standing, bladder problems, or trouble with sleep and breathing. There is no single test that proves it, so doctors often use brain scans such as MRI and other tests that check blood pressure, heart rate, bladder function, or sleep to support the diagnosis and rule out other causes, including Parkinson disease. Genetic testing is not usually part of diagnosing multiple system atrophy because it is not usually passed down in families.
Stages of Multiple system atrophy
Multiple system atrophy does not have defined progression stages. This is because symptoms can build up in different ways from one person to another, rather than following one clear step-by-step pattern. Often the process begins when you notice changes in daily life, and the early symptoms of multiple system atrophy may look like Parkinson’s disease, balance problems, dizziness on standing, bladder trouble, or changes in blood pressure control. Doctors usually diagnose and monitor multiple system atrophy by tracking symptoms over time, examining movement and balance, checking blood pressure lying down and standing, and sometimes using brain scans or other tests to rule out similar conditions.
Outlook and prognosis
Multiple system atrophy usually progresses steadily over years, with worsening problems in movement, balance, blood pressure control, speech, swallowing, and daily functioning. The condition is serious and life-shortening, and average survival is often about 6 to 10 years after symptoms begin, although some people live longer or decline more quickly. Prognosis tends to be poorer when severe autonomic failure, frequent falls, swallowing difficulty, or early breathing problems develop. Pneumonia, injuries from falls, sudden death during sleep, and complications of immobility are among the more common causes of death. While medicines, rehabilitation, and supportive care can improve comfort and function, they do not stop disease progression. Early planning for nutrition, mobility, speech and swallowing support, and advance care needs can meaningfully improve quality of life as the disease advances.
Long-term effects
Multiple system atrophy can affect day-to-day life in several ways over time, often making movement, blood pressure control, and basic body functions harder to manage. As the condition advances, many living with multiple system atrophy need more support with walking, eating, speaking, and personal care. Thinking about the long-term effects helps explain why follow-up care often involves several specialists, not just one doctor. The speed of change can vary, but doctors usually expect multiple system atrophy to be a serious, progressive illness.
Stiffness, slowness, poor coordination, and balance problems often become more noticeable over time. For many, this can mean more falls, trouble turning in tight spaces, and eventually needing a cane, walker, or wheelchair.
Multiple system atrophy commonly causes a sharp drop in blood pressure when standing, which can lead to dizziness, blurred vision, or fainting. Some may find that simple tasks like getting out of bed or standing in line become much harder.
Bladder urgency, leakage, trouble emptying the bladder, constipation, and sexual problems can become long-term issues. These changes can affect sleep, confidence, and daily routines as much as the movement problems do.
Speech may become softer, slower, or harder for others to understand as multiple system atrophy progresses. Swallowing can also become difficult, raising the risk of choking, weight loss, dehydration, and chest infections.
How is it to live with Multiple system atrophy?
Living with multiple system atrophy often means navigating a body that becomes less automatic over time: balance can feel unreliable, speech may grow softer, and everyday tasks like walking, dressing, eating, or getting up from a chair can take much more effort. Many people living with multiple system atrophy also deal with dizziness from low blood pressure, bladder problems, sleep changes, and stiffness or slowness, so daily routines often need planning, mobility aids, and help from others. For family and friends, the condition can gradually shift roles at home as they take on more caregiving, transportation, and emotional support, which can be exhausting, but with rehabilitation, symptom-focused treatment, and practical adaptations, many still find ways to protect comfort, communication, and connection.
Treatment and drugs
Multiple system atrophy has no cure yet, so treatment focuses on easing symptoms and helping people stay as safe, active, and comfortable as possible. Treatment plans often combine several approaches, such as medicines to raise low blood pressure, drugs that can modestly help stiffness or slowness in some people, and treatment for bladder problems, constipation, sleep issues, or trouble with movement and balance. Many living with multiple system atrophy also benefit from physical, occupational, and speech therapy, especially when walking, swallowing, or speaking becomes harder in daily life, like getting up from a chair or finishing a meal without coughing. Not every treatment works the same way for every person, so doctors often adjust care over time as symptoms change. In later stages, supportive care, mobility aids, and careful planning around swallowing and breathing can become an important part of treatment for multiple system atrophy.
Can you cure Multiple system atrophy?
No, there is currently no cure for multiple system atrophy. Treatment focuses on easing symptoms and helping with day-to-day life, such as improving movement, raising low blood pressure, and managing bladder, sleep, or breathing problems. Rehab, supportive care, and medicines can help some people feel better for a time, but they do not stop the disease.
Non-drug treatment
Day-to-day life with Multiple system atrophy often becomes harder because movement, balance, blood pressure, speech, swallowing, bladder control, and breathing can all be affected at once. Non-drug care focuses on keeping you safe, comfortable, and as independent as possible for as long as possible. Managing this condition often means combining rehabilitation, lifestyle changes, nutrition support, and practical equipment rather than relying on one single therapy. The best plan is usually tailored over time, since symptoms can change and not every approach works the same way for everyone.
Physical therapy can help with walking, balance, transfers, and muscle stiffness so daily tasks feel safer. Many living with Multiple system atrophy use strength work, stretching, and gait training to lower fall risk and keep moving as steadily as possible.
Occupational therapy focuses on everyday activities like dressing, bathing, cooking, and getting around the home. Some may find that grab bars, shower chairs, raised toilet seats, and small changes in layout make routines easier and safer.
Speech and language therapy can help when speech becomes soft, slurred, or tiring and when swallowing starts to feel difficult. Structured programs, like voice exercises and swallow training, can help protect communication and reduce choking risk.
A dietitian and swallowing specialist can suggest food textures and eating strategies that are easier and safer to manage. If weight loss, dehydration, or frequent choking become a problem, tube feeding may sometimes be discussed to support nutrition.
Your genes may have an impact on how drugs work for you
For people living with multiple system atrophy, genetic differences are not currently used in routine care to predict which medicines will work best or cause side effects, because there is not enough clear evidence for the drugs commonly used to ease symptoms. In day-to-day life, medicine response is more often shaped by the condition itself, such as large swings in blood pressure, stiffness, dizziness, sleep problems, or bladder trouble, so one person may feel better while another gets little help or more side effects from the same treatment. Researchers are still studying whether inherited differences play a role, but for now, treatment is usually adjusted by watching closely how someone feels and functions over time.
Pharmacological treatments
Treatment for multiple system atrophy focuses on easing symptoms and helping with day-to-day function, because there is not yet a drug that can stop the disease itself. The medicines used depend on which problems are most troublesome, such as stiffness and slowness, fainting from low blood pressure, bladder trouble, sleep symptoms, or constipation. Not everyone responds to the same medication in the same way. In multiple system atrophy, doctors often adjust treatment over time as symptoms change.
Levodopa, usually combined with carbidopa, is often tried for slowness, stiffness, and other movement symptoms in multiple system atrophy. Some people improve, but the benefit is often smaller or shorter-lasting than in Parkinson disease.
Midodrine, droxidopa, and fludrocortisone are commonly used when standing causes dizziness, fainting, or heavy fatigue because blood pressure drops. These medicines can help with one of the early symptoms of multiple system atrophy, though blood pressure must also be checked while lying down.
Medicines such as mirabegron or oxybutynin may help with urgency, frequency, and leakage. Because some bladder drugs can worsen constipation, dry mouth, or confusion, doctors choose them carefully.
Tamsulosin or similar drugs may sometimes be used if the bladder does not empty well, although they can lower blood pressure further in people with multiple system atrophy. In some cases, medicine is not enough and catheter-based bladder care is needed instead.
Genetic influences
When several relatives have balance trouble, falls, fainting, or Parkinson-like movement symptoms, it is easy to wonder whether genes are involved in multiple system atrophy. It’s natural to ask whether family history plays a role. For most people with multiple system atrophy, doctors do not find a clear inherited cause, and the condition usually appears sporadically rather than being passed down directly from parent to child. Researchers have found a few gene changes, including ones in SNCA and COQ2, that may raise the risk in some families or populations, but these explain only a small share of cases. Having one of these gene changes does not mean someone will definitely develop MSA, and many people with MSA have no known family history at all. If you are wondering whether multiple system atrophy is hereditary, the short answer is usually no, although genetics may slightly increase risk for some people.
Is Multiple system atrophy genetic?
Genetics do not seem to be a major cause of Multiple system atrophy. Most cases are not inherited, although certain genetic variations may slightly affect risk, and research is ongoing to better understand this link.
Having a genetic risk is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not directly affect health and instead reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than making the diagnosis certain, especially when more than one gene and environmental factors play a part. In other cases, though, one well-characterized variant in a particular gene may be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
In multiple system atrophy, treatment is usually guided by the symptoms causing the most trouble day to day, such as feeling faint when standing, bladder problems, stiffness, or sleep-related symptoms, rather than by a specific genetic test result. At this point, there is no well-established gene test that routinely tells doctors which drug will work best for multiple system atrophy or which side effects are most likely. If you have wondered whether genetic testing can help guide treatment for multiple system atrophy, the answer is usually not yet in routine care, although testing may sometimes be used when the diagnosis is unclear or in research studies. Genetics is only one factor, and for many people living with multiple system atrophy, medicine response is shaped more by the stage of the illness, blood pressure changes, swallowing problems, kidney or liver function, and other medicines being taken. That is why doctors often start with low doses and adjust carefully, especially for drugs used for low blood pressure, movement symptoms, bladder symptoms, or sleep problems. Researchers are still studying whether certain genetic changes might one day help predict treatment response in multiple system atrophy, but that is not a standard part of care yet.
Interactions with other conditions
For many living with multiple system atrophy, day-to-day problems rarely happen in isolation. This connection brings us to how multiple system atrophy can overlap with other conditions, especially Parkinson-like disorders, sleep breathing problems, bladder infections, and blood pressure disorders. Early symptoms of multiple system atrophy can look a lot like Parkinson’s disease, which can delay the right diagnosis and affect treatment choices. Many with multiple system atrophy also develop major drops in blood pressure when standing, and if they also have heart disease, diabetes, or dehydration, dizziness and falls can become more likely. Trouble swallowing and weaker cough can raise the risk of food or liquid going into the lungs, which may lead to chest infections such as aspiration pneumonia. Sleep problems are also common, and when multiple system atrophy occurs alongside sleep apnea or severe constipation, fatigue, poor concentration, and daily discomfort can become harder to manage.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Multiple system atrophy?
Parkinson's disease is the condition most often confused with multiple system atrophy, especially early on, because both can cause slowed movement, stiffness, balance trouble, and falls. Doctors may also consider dementia with Lewy bodies, which can affect movement and blood pressure and often brings early changes in thinking or seeing things that are not there, and progressive supranuclear palsy, which often causes marked balance problems and early falls. In some people, pure autonomic failure, a disorder that mainly affects automatic body functions like blood pressure, bladder control, and sweating, can also look similar at first.
History
People living with multiple system atrophy often spend years searching for answers before the picture becomes clear. That is partly because the condition was not always recognized as a single disorder. In the past, doctors described separate syndromes based on the symptoms they could see, such as severe balance problems, stiffness and slowness that looked like Parkinson disease, or major trouble with automatic body functions like blood pressure, bladder control, and sweating. For many, this meant symptoms that seemed unrelated at first, like fainting when standing up and increasing clumsiness, were not immediately linked together.
As medical science evolved, specialists began to realize these different patterns could belong to the same underlying illness. During the 20th century, terms such as Shy-Drager syndrome, striatonigral degeneration, and olivopontocerebellar atrophy were used for what are now understood to be parts of the multiple system atrophy spectrum. This shift mattered because it helped doctors see that multiple system atrophy can affect movement, balance, and the body’s automatic functions at the same time, even though the mix of symptoms varies from one person to another.
By the late 1960s and later decades, careful studies of brain tissue after death helped confirm that these syndromes were closely related. Researchers found a shared pattern of damage in several brain systems, which is why the name multiple system atrophy came into use. The name reflects what doctors were seeing: more than one control system in the brain and nervous system was being affected, not just the areas linked with movement alone.
In recent decades, awareness has grown, and doctors have become better at recognizing early symptoms of multiple system atrophy while someone is still alive. Brain scans, improved clinical criteria, and closer follow-up have all helped, although diagnosis can still be difficult in the early stages because symptoms may overlap with Parkinson disease or other neurologic conditions. Researchers later identified a genetic contribution in a small number of cases, but most people with multiple system atrophy do not have a clear family history.
The history of multiple system atrophy is, in many ways, a story of clearer recognition over time. What once seemed like several separate illnesses is now understood as one condition with different patterns. Knowing this history helps explain why diagnosis can still take time, and why modern care focuses on the full range of symptoms rather than just one part of the condition.